You are here » Home » Companies » Company Overview » Brawn Biotech Ltd

Brawn Biotech Ltd.

BSE: 530207 Sector: Others
NSE: N.A. ISIN Code: INE899B01015
BSE LIVE 14:50 | 22 Sep 52.50 -1.50
(-2.78%)
OPEN

55.00

HIGH

56.00

LOW

52.50

NSE 05:30 | 01 Jan Stock Is Not Traded.
OPEN 55.00
PREVIOUS CLOSE 54.00
VOLUME 1650
52-Week high 95.60
52-Week low 43.00
P/E 19.23
Mkt Cap.(Rs cr) 16
Buy Price 52.50
Buy Qty 5.00
Sell Price 55.00
Sell Qty 50.00
OPEN 55.00
CLOSE 54.00
VOLUME 1650
52-Week high 95.60
52-Week low 43.00
P/E 19.23
Mkt Cap.(Rs cr) 16
Buy Price 52.50
Buy Qty 5.00
Sell Price 55.00
Sell Qty 50.00

Brawn Biotech Ltd. (BRAWNBIOTECH) - Chairman Speech

Company chairman speech

BRAWN PHARMACEUTICALS LIMITED ANNUAL REPORT 2008-2009 CHAIRMAN'S REPORT Dear Shareholders, lextend hearty welcome to you on the eve of the Annual General Meeting of the Company. At the very outset, I would like to share with all of you my deep sense of satisfaction over the sterling results achieved by your Company. I am extremely happy to report to you that despite, all. adverse and challenging circumstances, your Company has fared very well during this year. Your company is trying to reduce the debt, increase the profitability and significantly improve the networth. The year 2008-09 has been odd year globally for number of significant reasons. Meltdown of major economies, world wide recession, liquidity crunch, de-growth in GDPs, unprecedented jobs cuts, near bankruptcy situation for many corporate giants of the developed countries and increased threat of terrorism than ever.before impacted the lives of human beings. India was not immune to these events. However, Indian financial and banking sector was stable and timely economic stimulants implemented by the Government brought stability. Further boost was received by peoples mandate to a stable Government at the centre. Opening up of financial and insurance sectors to foreign ,investors and thrust given to the growth has helped the country in maintaining sustained growth and thereby boosting up investor's confidence in the Indian economy. While all these events happening around the world, no exception to our country, your Company has recorded an unprecedented growth in income from operations and recorded increase in profits before tax to Rs. 41.41 Lacs. Revenues for the year at Rs. 409.94 lacs were higher by 442.41 % compared to the previous year. This was achieved through an increased focus on securing profitable jobs and implementing a sustained efficiency program across the enterprise , which includes working towards improving cash collection, controlling, expenditure and optimizing its resources wherever possible. These initiatives are showing visible success in all major financial indicators of your Company's results for the year. In view of the increasing profits , your company need to vipe off its losses accumulated over the years & thus is unable to distribute any dividends. Still, we hope that if the progress goes on like this, we will be distributing dividends soon. I am please to inform that the Bombay Stock Exchange has revoked the, suspension of trading on the equity shares of the Company with effect from 29th May 2009. Thus the trading of the shares of the Company has started on Bombay Stock Exchange. Soon the Delhi Stock Exchange is also starting its Online `trading Platform facilitating trading on the equity share of the Company at the DSE's trading terminals across the country. Finally, I wish to record my sincere thanks to Brawn Group for their unstinted support and contribution in turnaround of your Company. I also wish to place on record thanks to my colleagues on the Board, shareholders, suppliers, customers, bankers and employees at all levels for their continued support. B. R. Gupta CHAIRMAN